Here's Why DaVita HealthCare (DVA) is a Strong Momentum Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Is DaVita (DVA) Stock Outpacing Its Medical Peers This Year?
Here is how DaVita HealthCare (DVA) and Twist Bioscience (TWST) have performed compared to their sector so far this year.
DaVita HealthCare (DVA) Sees a More Significant Dip Than Broader Market: Some Facts to Know
The latest trading day saw DaVita HealthCare (DVA) settling at $143.18, representing a -0.46% change from its previous close.
Are Investors Undervaluing DaVita (DVA) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
DaVita (DVA) Hits 52-Week High: What's Aiding the Stock?
Investors are optimistic about DaVita's (DVA) strength in kidney care.
DaVita Inc. (DVA) Hit a 52 Week High, Can the Run Continue?
DaVita HealthCare (DVA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Why DaVita HealthCare (DVA) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Is DaVita (DVA) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
DaVita (DVA) Gains 34.5% YTD: What's Driving the Stock?
DaVita's (DVA) shares gain on the back of strong fundamentals. However, dependence on commercial payers can be a cause of concern.
